• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

福提霉素A的衍生物O-去甲基福提霉素A的抗菌活性比较

Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.

作者信息

Girolami R L, Stamm J M

出版信息

Antimicrob Agents Chemother. 1980 Nov;18(5):766-72. doi: 10.1128/AAC.18.5.766.

DOI:10.1128/AAC.18.5.766
PMID:7447430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC284089/
Abstract

The in vitro antimicrobial activity of O-demethylfortimicin A (ODMF), a derivative of fortimicin A, was compared with those of fortimicin A and gentamicin against a spectrum of 256 organisms. All three antibiotics were active in low concentrations against all strains of Enterobacteriaceae, Acinetobacter sp., and Staphylococcus aureus, with ODMF most active against Proteus mirabilis, indole-positive Proteus, and Providencia and gentamicin most active against other species. Activity of each of the antibiotics against group D streptococci was poor. The overall activity of ODMF was superior to that of fortimicin A for all groups of organisms examined and was most pronounced, approximately three-fold, against strains of Pseudomonas aeruginosa. Both ODMF and fortimicin A were resistant to the action of several aminoglycoside-inactivating enzymes, with the exception of 3-N-acetyltransferase-I. ODMF and fortimicin A showed similar rapid bactericidal effects at multiples of the minimum inhibitory concentration and equivalent synergistic activity against enterococci when combined with penicillin G. The combination of carbenicillin with ODMF, fortimicin A, or gentamicin was synergistic for approximately 80% of the P. aeruginosa strains tested. Inactivation of ODMF and fortimicin A when combined with carbenicillin in vitro was minimal or absent, whereas gentamicin was substantially inactivated under similar conditions. ODMF, fortimicin A, and gentamicin exhibited protective activity in mice infected with Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris, S. aureus, or P. aeruginosa. Gentamicin was the most active, followed by ODMF and fortimicin A. The superior in vitro activity of ODMF compared with fortimicin A against P. aeruginosa was confirmed in vivo.

摘要

将福提霉素A的衍生物O - 去甲基福提霉素A(ODMF)的体外抗菌活性与福提霉素A和庆大霉素针对256种菌株的抗菌活性进行了比较。这三种抗生素在低浓度时对所有肠杆菌科菌株、不动杆菌属和金黄色葡萄球菌均有活性,其中ODMF对奇异变形杆菌、吲哚阳性变形杆菌和普罗威登斯菌活性最强,庆大霉素对其他菌种活性最强。每种抗生素对D组链球菌的活性都很差。在所检测的所有菌株组中,ODMF的总体活性均优于福提霉素A,对铜绿假单胞菌菌株的活性优势最为明显,约为其三倍。ODMF和福提霉素A均对几种氨基糖苷类失活酶的作用具有抗性,但3 - N - 乙酰转移酶 - I除外。ODMF和福提霉素A在最低抑菌浓度倍数下显示出相似的快速杀菌作用,与青霉素G联合使用时对肠球菌具有同等的协同活性。羧苄西林与ODMF、福提霉素A或庆大霉素联合使用时,对约80%的受试铜绿假单胞菌菌株具有协同作用。ODMF和福提霉素A与羧苄西林在体外联合使用时的失活作用极小或不存在,而庆大霉素在类似条件下会大量失活。ODMF、福提霉素A和庆大霉素在感染大肠杆菌、肺炎克雷伯菌、普通变形杆菌、金黄色葡萄球菌或铜绿假单胞菌的小鼠中均表现出保护活性。庆大霉素活性最强,其次是ODMF和福提霉素A。ODMF在体外对铜绿假单胞菌的活性优于福提霉素A,这一点在体内也得到了证实。

相似文献

1
Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.福提霉素A的衍生物O-去甲基福提霉素A的抗菌活性比较
Antimicrob Agents Chemother. 1980 Nov;18(5):766-72. doi: 10.1128/AAC.18.5.766.
2
Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.新氨基糖苷类抗生素福提霉素A和B。IV. 福提霉素A与其他氨基糖苷类药物的体外研究。
J Antibiot (Tokyo). 1977 Jul;30(7):564-70. doi: 10.7164/antibiotics.30.564.
3
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.化合物A49759,福提霉素A的3-O-去甲基衍生物:与其他六种氨基糖苷类抗生素的体外比较
Antimicrob Agents Chemother. 1980 Nov;18(5):773-9. doi: 10.1128/AAC.18.5.773.
4
[Clinical and bacteriological study of O-demethylfortimicin A sulfate in urinary infection].硫酸O-去甲基福提霉素A在泌尿系统感染中的临床与细菌学研究
Pathol Biol (Paris). 1986 May;34(5):490-3.
5
In vitro evaluation of tobramycin, a new aminoglycoside antibiotic.新型氨基糖苷类抗生素妥布霉素的体外评价
Antimicrob Agents Chemother. 1972 May;1(5):381-4. doi: 10.1128/AAC.1.5.381.
6
1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides.
J Antibiot (Tokyo). 1978 May;31(5):385-93. doi: 10.7164/antibiotics.31.385.
7
The in-vitro activity of O-demethylfortimicin.O-去甲基福提霉素的体外活性。
J Antimicrob Chemother. 1983 Feb;11(2):181-5. doi: 10.1093/jac/11.2.181.
8
Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests.福提霉素A与其他五种氨基糖苷类药物的抗菌活性及影响药敏试验的因素
Antimicrob Agents Chemother. 1981 Jan;19(1):122-9. doi: 10.1128/AAC.19.1.122.
9
Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.
J Antibiot (Tokyo). 1979 Jan;32(1):29-35. doi: 10.7164/antibiotics.32.29.
10
Synergistic activities of fortimicin A and beta-lactam antibiotics against Pseudomonas aeruginosa.福提霉素A与β-内酰胺类抗生素对铜绿假单胞菌的协同活性。
Antimicrob Agents Chemother. 1981 Jul;20(1):33-7. doi: 10.1128/AAC.20.1.33.

引用本文的文献

1
Synthesis of 3-O-demethylfortimicins.3-O-去甲基弗氏菌素的合成
Antimicrob Agents Chemother. 1980 Nov;18(5):761-5. doi: 10.1128/AAC.18.5.761.
2
In vitro and in vivo antibacterial activities of K-4619, a new semisynthetic aminoglycoside.新型半合成氨基糖苷类药物K-4619的体外和体内抗菌活性
Antimicrob Agents Chemother. 1984 Aug;26(2):187-91. doi: 10.1128/AAC.26.2.187.
3
3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.3 - O - 去甲基福提霉素A:纸片扩散法药敏试验的体外活性及解释性抑菌圈标准
Eur J Clin Microbiol. 1984 Dec;3(6):531-7. doi: 10.1007/BF02013613.
4
Aminoglycoside research 1975-1985: prospects for development of improved agents.1975 - 1985年氨基糖苷类药物研究:改进型药物的开发前景
Antimicrob Agents Chemother. 1986 Apr;29(4):543-8. doi: 10.1128/AAC.29.4.543.

本文引用的文献

1
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.化合物A49759,福提霉素A的3-O-去甲基衍生物:与其他六种氨基糖苷类抗生素的体外比较
Antimicrob Agents Chemother. 1980 Nov;18(5):773-9. doi: 10.1128/AAC.18.5.773.
2
In vitro and in vivo antibacterial activity of KW1070, a new aminoglycoside antibiotic.新型氨基糖苷类抗生素KW1070的体外和体内抗菌活性
Antimicrob Agents Chemother. 1980 Feb;17(2):138-43. doi: 10.1128/AAC.17.2.138.
3
Synthesis of 3-O-demethylfortimicins.3-O-去甲基弗氏菌素的合成
Antimicrob Agents Chemother. 1980 Nov;18(5):761-5. doi: 10.1128/AAC.18.5.761.
4
Synergy of penicillin and gentamicin against Enterococci.青霉素与庆大霉素对肠球菌的协同作用。
J Infect Dis. 1971 Dec;124 Suppl:S207-9. doi: 10.1093/infdis/124.supplement_1.s207.
5
Laboratory and clinical conditions for gentamicin inactivation by carbenicillin.
Arch Intern Med. 1972 Dec;130(6):887-91.
6
Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin.铜绿假单胞菌实验性感染中的抗生素协同作用。II. 羧苄西林、头孢噻吩或头孢乙腈与妥布霉素或庆大霉素联合使用的效果。
J Infect Dis. 1974 Feb;129(2):124-33. doi: 10.1093/infdis/129.2.124.
7
The carbenicillin-gentamicin combination against Pseudomonas aeruginosa. Correlation of effect with gentamicin sensitivity.羧苄青霉素-庆大霉素联合用药治疗铜绿假单胞菌。疗效与庆大霉素敏感性的相关性。
Ann Intern Med. 1974 Nov;81(5):584-7. doi: 10.7326/0003-4819-81-5-584.
8
Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.妥布霉素、阿米卡星和庆大霉素单独及与羧苄西林联合使用对铜绿假单胞菌的比较活性
Antimicrob Agents Chemother. 1974 Oct;6(4):442-6. doi: 10.1128/AAC.6.4.442.
9
Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin.羧苄西林使庆大霉素失活的临床及实验室证据。
Lancet. 1971 Feb 6;1(7693):261-4. doi: 10.1016/s0140-6736(71)91001-4.
10
Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.铜绿假单胞菌对单独使用妥布霉素或庆大霉素以及与羧苄西林联合使用的敏感性。
Antimicrob Agents Chemother. 1975 Sep;8(3):300-4. doi: 10.1128/AAC.8.3.300.